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Abstract 
The calcium sensing receptor (CaSR) is a member of the largest family of cell surface receptors, the G protein-
coupled receptors involved in calcium homeostasis. Studies identified a crucial role for the CaSR in systemic 
calcium homeostasis through its ability to sense small changes in circulating calcium concentration and to 
combine this information to intracellular signaling pathways that influence parathyroid hormone secretion. The 
CaSR is the target of small molecule allosteric modifiers, either activators, calcimimetics, or inhibitors, 
calcilytics. The presence of CaSR protein in tissues is not directly involved in regulating mineral ion homeostasis 
points to a role for the CaSR in other cellular functions including the control of cellular proliferation, 
differentiation and apoptosis. This review will provide a comprehensive exploration of the different aspects of 
tissue expression patterns, and will relate their impact on the functionality of the CaSR from a molecular 
perspective. 
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Calcium sensing receptor 
The calcium-sensing receptor (CaSR) is a G 
protein-coupled receptor (GPCR) in the plasma 
membrane. The CaSR gene is located from base 
pair 121,902,529 to base pair 122,005,349 on long 
q arm of chromosome 3. It plays an essential role in 
calcium ion homeostasis, cellular proliferation, 
differentiation and apoptosis (Diez-Fraile et al., 
2013). The CaSR is composed of three main 
regions: a large extracellular domain, where the 
interaction with the Ca2+ occurs, a seven 
transmembrane domain that is a common feature of 
all GPCRs, and a carboxyl-terminal intracellular 
tail, necessary for Ca2+ mediated activation of G 
proteins, cell surface expression and phospholipase 
C activation, among other functions (Masvidal et 
al., 2013). Calcium sensing receptor is activated by 
many molecules such as polyamines and l-amino 
acids. The extracellular calcium ion is the primary  
physiological ligand for CaSR. Binding of the 
ligand with the receptor induces the change in the 
conformation of the receptor, which leads to 'ligand 
biased signaling'. Alteration in CaSR expression 
and function are associated with cancer progression. 
Interestingly, the CaSR appears to act both as a 
tumour suppressor and an oncogene, depending on 
the condition (Woudstra et al., 1990). Reduced 
expression of the CaSR occurs in both parathyroid 
and colon cancers, leading to loss of the growth 
suppressing effect of high calcium ion. On the other 
hand, activation of the CaSR might facilitate 
metastasis to bone in breast and prostate cancer. A 
deeper understanding of the mechanisms driving 
CaSR signalling in different tissues, aided by a 
systems biology approach, will be instrumental in 
developing novel drugs that target the CaSR or its 
ligands in cancer (Brennan et al., 2013). Three 
functionally relevant polymorphisms clustered at 
the signal transduction region of the CaSR 
(rs1801725, rs1042636 and rs1801726) were 
analyzed and assessed for genetic variants 
producing a less active receptor are associated with 






Atlas Genet Cytogenet Oncol Haematol. 2014; 18(7) 533 
more aggressive disease course (Masvidal et al., 
2013).  
Calcium (Ca2+) is a vital cation involved in diverse 
biologic processes ranging from bone formation 
and neurotransmission to hormone secretion and 
muscle contraction. The CaSR is expressed 
abundantly in the parathyroid hormone (PTH) 
producing chief cells of the parathyroid gland. 
Tissues in which the CaSR is expressed where it is 
likely to play a mineral ion homeostatic role 
include, skeletal tissues (Chang et al., 2008), 
osteoclasts and their precursors (Mentaverri et al., 
2006), osteoblasts and their precursors, osteocytes, 
chondrocytes (Liaw et al., 1992) and placenta 
(Ayerdi, 1978). Tissues in which the CASR is 
expressed at lower levels and is likely to play roles 
unrelated to mineral ion homeostasis include 
neurons and glia of the brain (Ruat et al., 1995), 
keratinocytes (Oda et al., 1998), vascular smooth 
muscle cells (Molostvov et al., 2007), 
hematopoietic stem cells (in blood and bone 
marrow) (Adams et al., 2006), stomach (Ray et al., 
1997), intestine (Geibel et al., 2006), colon (Cheng 
et al., 2002), liver (Canaff et al., 2001), pancreas 
(Bruce et al., 1999), and others. 
Disorders associated with CaSR 
Both gain-of-function and loss-of-function  
mutations have been reported in human CaSR. Gain 
of function mutations cause autosomal-dominant 
hypocalcemia with hypercalciuria as well as a 
variant form of Bartter's syndrome (Vargas-
Poussou et al., 2002). Heterozygosity for loss-of-
function mutations causes familial hypocalciuric 
hypercalcemia (FHH), whereas loss-of-function 
mutations in both alleles cause neonatal severe 
hyperparathyroidism (NSHPT) (Brown et al., 
1998). Population studies have suggested a possible 
role for CaSR variants in explaining human 
variation in serum Ca2+ and bone mineral density 
(BMD) (O'Seaghdha et al., 2010; Lorentzon et al., 
2001). Various studies have suggested a role for 
Casr in the regulation of renal Ca2+ handling. 
Increasing extracellular Ca2+ concentration elicits a 
marked increase in urinary Ca2+ excretion, 
independently of any obvious changes in calcium-
regulating hormones. There is abundant evidence 
that renal tubular Casr plays a role in the control of 
divalent cation reabsorption under both normal and 
pathologic conditions (Houillier and Paillard, 
2003). Clinical studies in humans under PTH clamp 
conditions suggested that alterations in serum Ca2+ 
modulate excretion of Ca2+, magnesium (Mg2+), and 
sodium (Na+) through a CaSR dependent 
mechanism (el-Hajj Fuleihan et al., 1998). Recent 
PTH clamp studies in mice showed similar results 
(Kantham et al., 2009). 
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CaSR in bone 
In bone, Ca2+, acting via the CaSR, stimulates 
recruitment and proliferation of preosteoblasts, their 
differentiation to mature osteoblasts, and synthesis 
and mineralization of bone proteins. Conversely 
Ca2+ inhibits the formation and activity and 
promotes apoptosis of osteoclasts, likely via the 
CaSR. These actions tend to mobilize skeletal Ca2+ 
during deficiency and retain it when Ca2+ is 
plentiful (Brown, 2013). Osteopontin, an acidic 
glycoprotein produced by osteoblasts is highly 
enriched at the endosteal surface and was also 
shown necessary for the HSC lodgment (Haylock 
and Nilsson, 2006; Nilsson et al., 2005). The 
endosteal niche has uniquely enriched calcium 
content relative to serum, CaSR expression has 
been demonstrated on HSCs, including the stem 
cell-enriched (lin-) Sca-1+c-Kit+ (LSK) population 
(Adams et al., 2006). Finally, in a series of elegant 
experiments using CaSR-/- mice, Adams et al. 
demonstrated that it is the mineral content of the 
niche dictates HSC localization via the CaSR 
(Adams et al., 2006). These mechanisms by which 
the CaSR dictates preferential localization of HSCs 
in the bone marrow endosteal region may provide 
additional insights for the fundamental 
interrelationship between the stem cell niche and 
stem cell fate (Theman and Collins, 2009). 
CaSR in kidney 
As the CaSR in the kidney controls calcium 
reabsorption and excretion and subsequently affects 
blood calcium concentration, agonists and 
antagonists of the CaSR could be used to control 
blood calcium concentration in patients who have 
lost their ability to regulate parathyroid hormone 
secretion (Houillier, 2013).  
Since extracellular Ca2+ is essential for the 
development of stable epithelial tight junctions 
(TJ), the endogenous CaSR is located at the 
basolateral pole of Madin-Darby Canine Kidney 
(MDCK) cells (Riccardi et al., 1998). It is co-
distributed with β-catenin on the basolateral 
membrane. Switching MDCK cells from low 
calcium media to media containing the normal 
calcium concentration significantly increases CaSR 
expression at both the mRNA and protein levels. 
Exposure of MDCK cells maintained in low-Ca2+ 
conditions to the CaSR agonists neomycin, Gd3+ or 
R-568 causes the transient relocation of the tight 
junction components ZO-1 and occludin to sites of 
cell-cell contact, while inducing no significant 
changes in the expression of mRNAs encoding 
junction-associated proteins. CaSR stimulation also 
increases the interaction between ZO-1 and the F-
actin-binding protein, I-afadin. This effect does not 
involve activation of the AMP-activated protein 
kinase. In contrast, CaSR inhibition by NPS-2143 
significantly decreases ZO-1/I-afadin interaction 
and reduces ZO-1 deposition at the cell surface 
following a Ca2+ switch from 5 µM to 200 µM 
[Ca2+]e. Pre-exposure of MDCK cells to the cell-
permeant Ca2+ chelator, BAPTA-AM, similarly 
prevents TJ-assembly caused by CaSR activation. 
Finally, stable transfection of MDCK cells with a 
cDNA encoding a human disease-associated gain-
of-function mutant form of the CaSR increases 
these cells' transepithelial electrical resistance in 
comparison to expression of the wild-type human 
CaSR (Jouret et al., 2013). In addition, more work 
is needed to decipher the molecular mechanisms 
through which CaSR determines calcium transport 
in the loop of Henle. 
CaSR in adipocytes 
CaSR being expressed in human adipocytes and 
adipocyte progenitor cells opens the possibility to 
investigate the physiological implications and thus 
contributing a novel component for adipose tissue 
biology research. Presence of the CaSR along with 
plasma membrane markers in adipocyte sub 
fractions is consistent with a putative role as a 
plasma membrane receptor in the adipose cells. It is 
theoretically plausible to relate CaSR signaling to 
proliferation, differentiation, and metabolic activity 
of adipose cells. For example, activation of the 
receptor in the adipocyte is expected to trigger 
signaling cascades (Hobson et al., 2003; Ward et 
al., 2002), which have been described in relevant 
phenomena in adipocyte metabolism such as 
adipogenesis and lipogenesis. Moreover, an 
increase in cytosolic Ca2+ as a consequence of 
CaSR activation, as reported in parathyroid cells 
(Roussanne et al., 2001), human intestinal epithelial 
cell lines (Gama et al., 2007), keratinocytes (Tu et 
al., 2001), and antral gastrin cells, among others, 
would also influence adipogenesis (Bost et al., 
2002; Pérez et al., 2004) and triglyceride storage in 
the adipocyte (Cifuentes et al., 2005).  
CaSR activation may interfere with the initial 
stages of adipocyte differentiation; however, these 
events do not seem to preclude adipogenesis from 
continuing. Even though adipogenesis (particularly 
in subcutaneous depots) is associated with insulin 
sensitivity and adequate adipose function, the 
implications of our findings in visceral adipocytes, 
especially in the context of inflamed AT and over 
nutrition, remain to be established (Villarroel et al., 
2013). Adipocyte differentiation and adipogenesis 
are closely related to obesity and obesity-induced 
metabolic disorders. The calcium-sensing receptor 
(CaSR) has been reported to play an antilipolytic 
role in human adipocyte and regulate cell 
differentiation in many tissues. Scientists have 
observed that activation of CaSR significantly 
promoted adipocyte differentiation and 
adipogenesis in human adipocytes. Gene expression 
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analysis revealed that the CaSR activation increased 
the transcription factor proliferator-activated 
receptor γ (PPARγ) and its downstream genes 
including CCAAT element binding protein α 
(C/EBPα), adipose fatty acid-binding protein (aP2), 
and lipoprotein lipase. The activity of glycerol-3-
phosphate dehydrogenase was also increased after 
the stimulation of CaSR. In addition, levels of 
cyclic AMP and calcium which have been shown to 
regulate PPARγ gene expression were significantly 
affected by the activation of CaSR. These effects 
could be suppressed by CaSR small interfering 
RNA (CaSR-siRNA) (He et al., 2012). Many 
findings suggest that activation of CaSR promotes 
differentiation and adipogenesis in adipocytes, 
which might be achieved by up-regulating PPARγ 
and its downstream gene expressions. Therefore, 
CaSR in adipocytes may be involved in the 
pathogenesis of obesity by promoting adipocyte 
differentiation and adipogenesis. 
CaSR in nervous system 
The calcium sensing receptor (CaSR) is expressed 
by subpopulations of neuronal and glial cells 
through out the brain and is activated by 
extracellular calcium. During development, the 
CaSR regulates neuronal cell growth and migration 
as well as oligodendroglial maturation and function. 
Emerging evidence suggests that in nerve terminals, 
CaSR is implicated in synaptic plasticity and 
neurotransmission (Ruat and Traiffort, 2013).  
The highest level of CaSR expression is within the 
region of the brain known as the sub fornical organ, 
which, due to an absence of a blood-brain barrier, is 
exposed to systemic fluid (Yano et al., 2004). CaSR 
mediated current regulates the bursting of action 
potentials and that subsequent depolarizing after 
potentials of neurons of the subfornical organ canal 
so be modulated by the CaSR (Washburn et al., 
2000). There is also abundant expression of the 
CaSR in the hippocampus and studies of neurons of 
the hippocampus have revealed that the CaSR 
mediated activation of calcium permeable, non 
selective cation channels can be induced by the 
CaSR agonist amyloid β peptide, which is 
excessively produced in patients with Alzheimer's 
disease (Ye et al., 1997). The expression of the 
CaSR within the nervous system is not limited to 
neuronal cells because the receptor has been 
detected in glial cells as well (Washburn et al., 
2000) CaSR identified in oligodendrocytes and 
microglia have also been found to regulate calcium 
activated potassium channels (Chattopadhyay et al., 
1998b). More recently, the CaSR has been found to 
be expressed in the tooth dental pulp, sensory 
axons, and trigeminal ganglion of rats, where it was 
shown to be involved in the regulation of blood 
flow (Magno et al., 2011). Very little is known 
about the role, if any, of the CaSR in brain tissue 
that has under gone trauma, but one study 
examining three different types of experimental 
brain lesions has shown that there is a delayed 
increase in CaSR mRNA 7 d after the initial injury 
(Mudò et al., 2009). Finally, evidence that the 
CaSR contributes to the pathogenesis of various 
brain disorders raises the possibility that 
pharmacological modulators of the CaSR may have 
therapeutic benefit. 
CaSR in breast 
The CaSR has been identified in both normal and 
malignant breast tissue by Northern analysis and 
immuno-histochemistry (Cheng et al., 1998). In 
normal breast cell lines, CaSR stimulation inhibits 
PTHrP secretion, whereas in breast cancer cell lines 
PTHrP secretion is increased by CaSR stimulation 
(VanHouten et al., 2004; Sanders et al., 2000). 
During lactation, activation of the CaSR in 
mammary epithelial cells downregulates 
parathyroid hormone-related protein (PTHrP) levels 
in milk and in the circulation, and increases calcium 
transport into milk. In contrast, in breast cancer 
cells the CaSR upregulates PTHrP production. A 
switch in G-protein usage underlies the opposing 
effects of the CaSR on PTHrP expression in normal 
and malignant breast cells. During lactation, the 
CaSR in normal breast cells coordinates a feedback 
loop that matches the transport of calcium into milk 
and maternal calcium metabolism to the supply of 
calcium. A switch in CaSR G-protein usage during 
malignant transformation converts this feedback 
loop into a feed-forward cycle in breast cancer cells 
that may promote the growth of osteolytic skeletal 
metastases (Kirchhoff and Geibel, 2006). Further 
investigations may lead to improved methodologies 
for clinical stem cell transplantation using 
pharmaceutical modulators of the CaR to enhance 
either stem cell engraftment to or mobilization from 
the bone marrow (Adams et al., 2006). 
CaSR in gastrointestinal tract 
The gastrointestinal tract consists of a system of 
organs designed to cope with the nutrient, 
electrolyte, and fluid absorption requirements of the 
body, as well as the secretion of excess electrolytes 
and fluids (Kirchhoff and Geibel, 2006). The CaSR 
has been identified in a number of the organs that 
constitute the gastrointestinal tract, including the 
esophagus, stomach, small intestine, and colon 
(Chattopadhyay et al., 1998a). Expression and 
function of the CaSR have been shown in some 
mammalian taste buds and basal cells of the 
esophagus. In human gastric mucous epithelial 
cells, stimulation of the CaSR, which is primarily 
expressed at the basolateral membrane, results in 
increases in both intracellular Ca2+ levels and the 
rate of proliferation (Rutten et al., 1999). In colonic 
myofibroblasts, stimulation of the CaSR up 
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regulated the expression and secretion of bone 
morphogenetic protein-2 in a PI3K-dependent 
manner, but decreased the expression of the bone 
morphogenetic protein-2 antagonist, Noggin (Peiris 
et al., 2007). In addition, the CaSR mediates a 
novel paracrine relationship between 
myofibroblasts and overlying epithelial cells in the 
colon. Thus, CaSR activators stimulate secretion of 
Wnt5a from myofibroblasts and expression of the 
Wnt5a receptor Ror2 in epithelial cells. CaSR-
mediated Wnt5a/Ror2 engagement stimulates 
epithelial differentiation and reduces expression of 
the receptor for tumor necrosis factor 1 (TNFR1). 
CaSR activators also modulate intestinal motility, 
inhibit Cl- secretion and stimulate Na+ absorption in 
both the small intestine and colon. Colonic epithelia 
from conditional and global CaSR knockout mice 
exhibit increased proliferation with increased 
Wnt/β-catenin signaling, demonstrating that the 
CaSR negatively modulates colonic epithelial 
growth (Macleod, 2009). The role of the CaSR in 
the regulation of cell proliferation and 
differentiation and results of several studies 
examining the preventive effects of a high calcium 
diet on colon cancer have led to the proposal that 
the use of therapeutic CaSR agonists may reduce 
the risk of colon cancer (Kirchhoff and Geibel, 
2006). 
CaSR in cancer 
The CaSR has recently been documented to be 
expressed in a variety of benign tumor and 
malignancies, often at expression levels that differ 
from those in their healthy counterparts like in 
breast cancer, prostate cancer, as well as in cancers 
originating from organs involved in Ca2+ 
homeostasis, including colorectal cancer and 
parathyroid adenomas (Sarkar and Kumar, 2012). A 
recent examination of publicly available gene 
expression data identified a variety of types of 
GPCRs (Dores and Trejo, 2012), including protease 
activated receptor and receptors for various 
chemokines, adenosine 2B, neuropeptide, 
metabotropic glutamate, and CaSR that are 
overexpressed in diverse type of cancer (Rozengurt, 
2007).  
Anti-proliferative effects of calcium in the colon are 
mediated, at least in part, via the calcium sensing 
receptor (CaSR), a vitamin D target gene. The 
expression of CaSR decreases during colorectal 
tumor progression and the mechanisms regulating 
its expression (Fetahu et al., 2013). The 
extracellular Ca2+-sensing receptor (CaSR) is a 
robust promoter of differentiation in colonic 
epithelial cells and functions as a tumor suppressor 
in colon cancer. CaSR mediates its biologic effects 
through diverse mechanisms. Loss of CaSR 
expression activates a myriad of stem cell-like 
molecular features that drive and sustain the 
malignant and drug-resistant phenotypes of colon 
cancer. This CaSR-null phenotype, however, is not 
irreversible and induction of CaSR expression in 
CaSR-null cells promotes cell death mechanisms 
and restores drug sensitivity. The CaSR also 
functions as a tumor suppressor in breast cancer and 
promotes cellular sensitivity to cytotoxic drugs. 
BRCA1 and CaSR functions intersect in breast 
cancer cells, and CaSR activation can rescue breast 
cancer cells from the deleterious effect of BRCA1 
mutations (Singh et al., 2013).  
High Ca2+ produced, CaSR mediated stimulation of 
proliferation as well as resistance to apoptosis. Thus 
it not only enhances tumor growth but also 
increases invasiveness and metastasis (Cheng et al., 
1998; Thomsen et al., 1998). The surface 
epithelium of the ovary is contiguous with the 
mesothelial lining of the peritoneum. Thus the 
ovarian surface epithelial (OSE) cells are actually 
derived from a mesodermal lineage (Auersperg et 
al., 1994). Increasing extracellular calcium from 0.2 
mM to 5 mM has a marked proliferative response in 
normal ovarian surface epithelial cells (Saxena et 
al., 2012). CaSR may mediate the growth of human 
ovarian surface epithelial cells by extracellular 
calcium (Saxena et al., 2012).  
CaSR is neither a potent oncogene nor tumor 
supressor; it does play an important role in Ca2+ 
homeostasis, which indirectly maintains a balance 
between proliferation and differentiation in 
response to change in extra cellular calcium level. 
Hence there should be a balanced intake of calcium 
rich diet, like patients suffering from colon or 
ovarian cancer should increase the calcium intake, 
while patients with prostate or breast cancer should 
decrease the intake of calcium rich food. CaSR can 
be considered as a molecule that can either promote 
or prevent tumor growth depending on the type of 
cancer. Targeting of receptor based on the cancer 
may offer a cure in designing new therapies, which 
might complement the existing therapies. 
Discussion 
The CaSR responds to a various range of stimuli 
extending well beyond that merely of calcium and 
these stimuli can pilot to the commencement of an 
extensive variety of intra cellular signaling 
pathways that in turn are able to regulate a diverse 
array of biological processes. The CaSR has been 
recognized as a novel molecular player in the 
determination of cellular fate with a fundamental 
impact on proliferation, apoptosis and 
differentiation in a varied array of tissues. The use 
of selective CaSR drugs, together with anti-sense 
and conditional gene knock-out technology, will 
definitely be of benefit in further unraveling the 
role of CaSR in cellular fate. CaSR agonists may be 
useful in treating hypertensive states characterized 
by an in appropriately elevated renin concentration, 
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as well, and may constitute a new approach for the 
prevention and treatment of numerous kidney 
disorders, such as diabetic nephropathy, through the 
above-mentioned nephroprotective effects. 
Calcimimetics could be useful in bone marrow 
transplants for stimulating homing, lodging, and 
engraftment of transplanted hematopoietic stem 
cells and progenitor cells. 
Conclusion 
Current findings have highlighted the variety of the 
CaSR because it has been observed to regulate an 
array of biological processes in a range of tissues. 
However, many of these conclusions, particularly 
those relating to the heart and nervous system, were 
drawn from in vitro studies, and further 
examination using in vivo based methods such as 
the generation of CaSR conditional knockouts is 
required to definitively demonstrate the receptor's 
role in these regulatory events. 
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